Full Length Research Paper
References
|
Ajayi AO, Ajayi EA, Fasakin KA (2009). CD4+ T-lymphocytes counts in adults with Human immunodeficiency virus infection at the medical department of a Tertiary health institution in Nigeria. Ann. Afr. Med. 8:257-260. Crossref |
||||
|
Akanmu AS, Akinsete I, Eshamaine AO, Davies AO, Okanny CC (2001). Absolute lymphocyte count, as a surrogate for CD4 cell count in monitoring response to antiretroviral therapy. Niger Postgrad. Med. J. 8:105-111. Pubmed |
||||
| Akinola NO, Olasode O, Adediran IA, Onayemi O, Murainah A, Irinoye O, Elujoba AA, Durosinmi MA (2007). The Search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting. HIV/AIDS CID. 39:579-581. | ||||
| Anastos K1, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, Hoover DR (2004). Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1 infected women receiving highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 4:383-392. | ||||
| Arthur A, Sahan B (2006). Use of total lymphocyte count vs CD4 cell count as a marker of immunity in HIV – Infected adults and children. Women, children and HIV resources for prevention and treatment and treatment. pp. 1-6. | ||||
|
Balter M (2003). How does HIV overcome the body's T-cell body guards? Sci. 278:1399-1400. Crossref |
||||
|
Beck EJ, Kupek EJ, Gompels MM, Pinching AJ (1996). Correlation between total and CD4 lymphocyte counts in HIV infections not making the good an enemy of the not so perfect. Int. J. STD AIDS. 6:422-428. Crossref |
||||
|
British HIV Association (BHIVA) (2000). Writing committee on behalf of the BHIVA executive committee. British HIV guidelines for the treatment of HIV-infected adults with anteratroviral therapy. HIV Med. 1:76-101. Crossref |
||||
|
Cheisson RE, Keruly JC, Moore Rd (2000). Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA 284:3128. Pubmed |
||||
| Chigu H, Hakim J, Dixon M (2006). Correlation between CD4 counts and total lymphocyte counts in HIV positive adults at Mpilo Hospital opportunistic infections clinic: AIDS 2006-XVI international AIDS conference: Abstract no: CDB1138. | ||||
|
Deresse D, Eskindir l (2008). Relationship between total lymphocyte count (TLC) and CD4 counts among people living with HIV, Southern Ethopia: a retrospective study. AIDS Res. Ther. 5:26. Crossref |
||||
|
Erhabor O, UKO EK, Adias T (2006). Absolute lymphocyte as a marker for CD4 T-lymphocyte count: Criterion for initiating antiretroviral therapy in HIV-infected Nigerians. Niger. J. Med. 15:56-59. Crossref |
||||
|
Gitura BM, Joshi MD, Lule GN, Anzala O (2007). Total lymphocyte counts as a surrogate marker for CD4 + T cell counts in initiating HAART at Kenyatta National Hospital, Nairobi. East Africa Med. J. 84:466-472. Pubmed |
||||
| Guarner J, Uribe-Zu-iga P, Hernandez-Tepichin G, Terán-Toledo X, del Río C (1996). Comparison of CD4+ T-cell counts in men and women recently diagnosed with HIV infection in Mexico. AIDS. 11:701-702. | ||||
|
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA, Fischl MA (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with HIV-infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:725-733. Crossref |
||||
|
Hanson DL, Chu SY, Farizo KM, Ward JW (1995). Distribution of CD4 + T lymphocytes at diagnosis of AIDS- defining and others HIV-related illnesses: The adult and adolescent spectrum of HIV disease project group. Arch. Intern. Med. 155:1537-1542. Crossref |
||||
| Hocqueloux L, Avettand-Fènoël V, Prazuck T, Mélard A, Legac E, Niang M, Mille C, Buret J, Rouzioux C (2013). In chronically HIV-1-infected patients long-term antiretroviral therapy initiated above 500 CD4/mm³ achieves better HIV-1 reservoirs' depletion and T-cell count restoration. Seventh International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Abstract WeAB0102,Kuala Lumpur. | ||||
|
Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS (2001). Rates of disease progression by baseline CD4 cell counts and viral load initiating triple drug therapy. JAMA 286:2568-2577. Crossref |
||||
|
Kilaru KR, Kumar A, Sippy N (2004). CD4 cell counts in adults with newly diagnosed HIV infection in Barbados. Pan. Am. J. Public Health. 16:302-307. Crossref |
||||
|
Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R (1999). Clinical progression and virological failure on HAART in HIV-1 patients: A prospective cohort study: Swiss HIV cohort study. Lancet. 353:863-868. Crossref |
||||
|
Mellors JW, Mu-oz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954. Crossref |
||||
|
Nyawira G, Elizabeth MO, Moses N, Dalton CW, Mbori-Ngacha D (2011). Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya. BMC infect. Dis. 11:259. Crossref |
||||
|
Shearer WT, Rosenblatt HM, Schluchter MD, Mofenson LM, Denny TN (1983). Immunologic targets of HIV infection: Tcells. Ann. NY Acad. Sci. 693:35-51. Crossref |
||||
|
Stein DS, Korvick JA, Vermund SH (1992). CD4 + lymphocyte cell enumeration for prediction of clinical course of HIV disease: A review. J. Infect. Dis. 165:352-363. Crossref |
||||
|
Tarwater PM, Margolick JB, Jin JH, Phair JP, Detels R, Rinaldo C, Giorgi J, Munoz A (2001). Increase and plateau of CD4 T-cell count in the 3(1/2) years after initiation of antirational therapy. J. Acquir. Immune Defic. Syndr. 27:168-175. Pubmed |
||||
| The President's Emergency Plan for AIDS Relief (PEPFAR, 2011), Next Generation Indicators Reference Guide. | ||||
| van der Ryst E, Kotze M, Joubert G, Steyn M, Pieters H, van der Westhuizen M, van Staden M, Venter C (1998). Correlation among total lymphocyte count, absolute CD4 count and CD4 percentage in a group of HIV-infected South Africa patients. J. Acquir. Immune Defic. Human Retroviral. 19:233-244. | ||||
| World Health Organization (WHO) (2004). Guidance on provider initiated HIV testing and counseling in health facilities. Geneva. World Health Organization, 2007. | ||||
| World Health Organization (WHO) (2005). Antiretroviral drugs for the treatment of HIV infection in Adults and Adolescents in resource-limited settings: Recommendations for a public Health Approach (2005 Revision) –Brief meeting Report. September, 2005. | ||||
| World Health Organization (WHO) (2002). Scaling up antiretroviral health in resource-limited settings. Guidelines for a public health approach. WHO, Geneva. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
